Collectively, these results showed that ATF5 transcriptionally upregulated PIK3AP1 and enhanced the PI3K/AKT/mTOR pathway to promote the survival of CTCL. This evidence concerns the gene ATF5 and primary cutaneous T-cell non-Hodgkin lymphoma.